KoprowskiH, SteplewskiZ, HerlynD, and HerlynM: Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci USA, 1978; 75:3405–3409.
2.
SteplewskiZ, HerlynM, HerlynD, ClarkWH, and KoprowskiH: Reactivity of monoclonal antibodies with melanoma cells freshly isolated from primary and metastatic melanoma. Eur J Immunol, 1979; 9:94–96.
3.
HerlynM, SteplewskiZ, HerlynD, and KoprowskiH: Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci USA, 1979; 76:1438–1442.
4.
HerlynD, HerlynD, SteplewskiZ, and KoprowskiH: Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma. Eur J Immunol, 1979; 9:657–659.
5.
KoprowskiH, SteplewskiZ, MitchellK, HerlynM, HerlynD, and FuhrerJP: Colorectal carcinoma antigens detected by hybridoma antibodies. Somat Cell Genet, 1979; 5:957–972.
6.
HerlynD, SteplewskiZ, HerlynM, and KoprowskiH: Inhibition of colorectal carcinoma tumor growth in the nude mice by monoclonal antibody. Cancer Res, 1980; 40:717–721.
7.
KoprowskiH, HerlynM, StepleskiZ, and SearsHF: Specific antigen in serum of patients with colon carcinoma. Science, 1981; 212:53–55.
8.
MagnaniJL, BrockhausM, SmithDF, GinsburgV, BlaszczykM, MitchellKF, SteplewskiZ, and KoprowskiH: A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science, 1981; 212:55–56.
9.
HerlynM, SearsHF, SteplewskiZ, and KoprowskiH: Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric and pancreatic cancer. J Clin Immunol, 1982; 2:135–140.
10.
SearsHF, HerlynM, Del VillanoB, SteplewskiZ, and KoprowskiH: Monoclonal antibody detection of a circulating tumor-associated antigen. II. A longitudinal evaluation of patients with colorectal cancer. J Clin Immunol, 1982; 2:141–149.
11.
SearsHF, HerlynD, HerlynM, GrotzingerPJ, SteplewskiZ, GerhardW, and KoprowsiH: Ex vivo perfusion of a tumor-containing colon with monoclonal antibody. J Surg Res, 1981; 31:145–150.
12.
SearsHF, HerlynM, SteplewskiZ, GrotzingerP, and KoprowskiH: Ex vivo perfusion of human colon with monoclonal colorectal cancer antibodies. Cancer, 1982; 49:1231–1235.
13.
AtkinsonBF, ErnstCS, HerlynM, SteplewskiZ, SearsHF, and KoprowskiH: Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Cancer Res, 1982; 42:4820–4823.
14.
SteplewskiZ, LubeckMD, and KoprowskiH: Human macrophages armed with murine IgG2a anti-tumor immunoglobulin destroy human cancer cells. Science, 1983; 221: 865–867.
15.
AkiyamaY, LubeckM, SteplewskiZ, and KoprowskiH: Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon. Cancer Res, 1984; 44:5127–5131.
SearsHF, AtkinsonB, MattisJ, ErnstC, HerlynD, SteplewskiZ, HayryP, and KoprowskiH: Phase I clinical trial of monoclonal antibody treatment of gastrointestinal tumors. Lancet, 1982; 1:762–765.
18.
SearsHF, HerlynD, SteplewskiZ, and KoprowskiH: Effects of monoclonal antibody immunotherapy on patients with gastrointestinal adenocarcinoma. J Biol Resp Mod, 1984; 3:138–150.
19.
SearsHF, HerlynD, SteplewskiZ, and KoprowkiH: Phase II clinical trial of a murine monoclonal antibody cytotoxic for gastrointestinal adenocarcinoma. Cancer Res, 1985; 45:5910–5913.
20.
SteplewskiZ, SearsHF, and KoprowskiH: Monoclonal antibody infusion in gastrointestinal cancer patients. Rec Result Cancer Res, 1986; 100:321–323.
21.
SearsHF, HerlynD, SteplewskiZ, and KoprowskiH: Initial trial use of murine monoclonal antibodies as immunotherapeutic agents for gastrointestinal adenocarcinoma. Hybridoma, 1986; 5:S109–S115.
22.
ErnstC, SearsHF, HerlynM, HerlynD, SteplewskiZ, and KoprowskiH: Detection of murine immunoglobulin in human tissues following therapeutic infusion of monoclonal antibody. Hybridoma, 1986; 5:S79–S86.
23.
SteplewskiZ, FoxK, GlickJ, and KoprowskiH: Human antimouse antibody response in patients treated with multiple infusions of monoclonal antibody CO17-1A. In: The Present and Future Role of Monoclonal Antibodies in the Management of Cancer. VaethJM, and MeyerJL, eds. Front Radiat Ther Oncol, 1990; 24:69–72.
